Clinical trial NCT01106040 - References

Breast Cancer — Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Citation(s)

•   Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SP, Faries MB, Averbook BJ, Martinez SR, Puleo CA, Messina JL, Christman L, Wallace AM
  Combined analysis of phase III trials evaluating [??mTc]tilmanocept and vital blue dye for identification of s
•   Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR
  Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast c

A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping

Details for clinical trial NCT01106040